Viewing Study NCT02963428


Ignite Creation Date: 2025-12-26 @ 10:34 AM
Ignite Modification Date: 2026-01-13 @ 11:33 AM
Study NCT ID: NCT02963428
Status: COMPLETED
Last Update Posted: 2019-08-14
First Post: 2016-10-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Teaching Appropriate Gestational Weight Gain
Sponsor: Geisinger Clinic
Organization:

Study Overview

Official Title: Teaching Appropriate Gestational Weight Gain
Status: COMPLETED
Status Verified Date: 2019-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: TAGG
Brief Summary: The study aims to improve obstetrical care by managing gestational weight gain (GWG) among high risk women in an effort to reduce maternal and fetal complications.
Detailed Description: The project is aimed at teaching women about the appropriate weight gain during pregnancy to optimize health outcomes for mothers and newborn babies. Obese gravida meeting inclusion criteria and none of the exclusion criteria will be offered enrollment in TAGG. Those that consent will be randomized to receive standard of care or enhanced care regarding gestational weight gain.

The primary outcome is the proportion of patients that gain less than 20 lbs over the course of the pregnancy. Secondary outcomes include patient knowledge and expectations, attitude about pregnancy weight gain, self-efficacy of ability to eat healthy, and eating, sleeping and physical activity behavior, perceived stress, psychological factors, patient-experience, involvement in care, and food security.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: